Pancreatic Cancer Translational Research

Pancreatic cancer claims five Australian lives every day and is one of the nation’s most lethal diseases. Despite aggressive treatment regimes, there has been no improvement in patient survival in the last decade. Evidence suggests that targeting cancer cells alone is not enough. The overall aim of the Pancreatic Cancer Translational Research group is to therapeutically target tumour cells and stromal pancreatic stellate cells (PSCs) which both contribute to chemoresistance in pancreatic cancer.

Group Leader Name
A/Prof Phoebe Phillips
Dr Phoebe Phillips
Research Area

Back to top